Therapeutic Drug Monitoring for Sirolimus in Children with Vascular Anomalies: What Can We Learn from a Retrospective Study

• मुख्य लेखकों: Ya-Hui Hu (लेखक), Yue-Tao Zhao (लेखक), Hong-Li Guo (लेखक), Yue Li (लेखक), Yuan-Yuan Zhang (लेखक), Jie Wang (लेखक), Xuan-Sheng Ding (लेखक), Ji-Jun Zou (लेखक), Feng Chen (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2024-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

<b>Objectives</b>: Sirolimus (SRL), a mammalian target of rapamycin inhibitor, has been widely used to treat patients with vascular anomalies (VAs). The objectives of this study were to summarize the routine blood SRL monitoring data for VAs children, to investigate the factors contribut...